1-3 of 3
Steven Pals
Close
Sort by
Journal Articles

High Prevalence of Oncogenic MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma: Implication for Therapy with Bruton's Kinase Inhibitors?

Sebastiaan Somers, MD MSc, Patty Jansen, MD PhD, Hendrik Veelken, MD PhD, Maarten Vermeer, MD PhD, Willem Kraan, MSc, Anne-Roos Schrader, MD, Ward Posthuma, MD PhD, Marcel Nijland, MD, Arjan Diepstra, MD PhD, Marie Jose Kersten, MD PhD, Steven Pals, MD PhD, Arjen Cleven, MD PhD MSc, Joost Vermaat, MD PhD MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 4000.
https://doi.org/10.1182/blood.V130.Suppl_1.4000.4000
Published: 2017
Journal Articles

Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model

Brief Report
Valeria Lascano, Marco Guadagnoli, Jan G. Schot, Dieuwertje M. Luijks, Jeroen E. J. Guikema, Katherine Cameron, Michael Hahne, Steven Pals, Erik Slinger, Thomas J. Kipps, Marinus H. J. van Oers, Eric Eldering, Jan Paul Medema, Arnon P. Kater
Journal: Blood
Blood (2013) 122 (24): 3960–3963.
https://doi.org/10.1182/blood-2013-04-497693
Published: 2013
Includes: Supplemental data
Journal Articles

Mirna Profiling Reveals Specific Patterns for Normal B Cell Subsets and B Cell Lymphomas with a Unique Burkitt Lymphoma Profile

Jan-Lukas Robertus, Geert Harms, Rogier Reijmers, Steven Pals, Yolanthe Swart, Klaas Kok, Stefano Rosati, Ed Schuuring, Gustaaf van Imhoff, Philip Kluin, Anke van den Berg
Journal: Blood
Blood (2008) 112 (11): 3763.
https://doi.org/10.1182/blood.V112.11.3763.3763
Published: 2008